Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SEATTLE, Jan. 03, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ:SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 42nd Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PT on Tuesday, January 9, 2024. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer.
Related news for (SANA)
- Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
- 24/7 Market News Snapshot 23 June, 2025 – Sana Biotechnology, Inc. Common Stock (NASDAQ:SANA)
- Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
- Sana Biotechnology to Present at June 2025 Investor Conferences
- Breaking News: MoBot’s Latest Update as of 05/20/25 03:00 PM